The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee. The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources essential to becoming successful investigators. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.

The Johns Hopkins University SKCCC has been invited to nominate one investigator for the NCCN 2027 YIA Program. Through its YIA Program, the NCCN Foundation invites proposals from young investigators with innovative ideas and an interest in improving the quality, effectiveness, equity, and accessibility of care provided to patients with cancer. A primary focus of the NCCN Foundation YIA Program is to identify and fund top investigators in the early stages of their careers interested in participating and contributing to cancer research.

The Johns Hopkins University School of Medicine announces the annual request for applications (RFA) for the Swim Across America (SAA) Translational Cancer Research Awards. The expectation is that SAA Awards will spark synergistic interactions among investigators and catalyze scientific achievements of the highest quality and impact. Applications are sought focused on translational research that aims to translate findings in fundamental research into medical practice and meaningful health outcomes. Applications are similarly free to focus on specific organ sites or on issues that span multiple cancer types. Research projects that help address cancer healthcare disparities are encouraged. Review will be based on their potential to influence our scientific understanding of cancer and our clinical, operational, and financial management of the disease.

The Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center (SKCCC) is pleased to announce the continuation of the request for applications (RFA) for the SKCCC Cancer Research Pilot Fund. The Pilot Fund will support one year project proposals up to $100,000 direct costs. The expectation is that SKCCC Cancer Research Pilot Fund will spark synergistic interactions among investigators and catalyze scientific achievements of the highest quality and impact. Applications are welcomed from across the spectrum of fundamental, translational, clinical, and epidemiologic research. Applications are similarly free to focus on specific organ sites or on issues that span multiple cancer types. Applications will be evaluated based on their potential to influence our scientific understanding of cancer and our clinical, operational, and financial management of the disease.

This Request for Applications (RFA) is specifically for the adult Translational grant mechanism. Each invited institution may submit one nomination. Translational research is a critical part of the research continuum, advancing basic laboratory discoveries toward clinical application to improve human health. This grant is restricted to adult cancer research in the preclinical or translational space, with a focus on bench to-bedside strategies. Research on ANY adult cancer type is eligible.